From: Exosomes: potential targets for the diagnosis and treatment of neuropsychiatric disorders
Disease | Cell-derived EVs | Cargos | Overcome | References |
---|---|---|---|---|
AD | Neuronal exosomes | Glycosphingolipids | Reduced Aβ and amyloid deposition | [98] |
SCI | Neuron-derived exosomes | Up-regulation of miR-124-3p | Inhibition of the activation of neurotoxic microglia and astrocytes protects against traumatic spinal cord injury | [17] |
Stroke and demyelinating disease | Microglia-derived EVs | Up-regulation of miR-23a-5p | Promote white matter repair | [102] |
TBI | Astrocyte-derived exosomes | NA | Reduce oxidative stress and neuronal apoptosis | [105] |
TBI | Macrophage derived exosomes-miR-21 (M-Exos-miR-21) | Down-regulation of miR-21 | Improve neuroinflammation, Improve blood–brain barrier (BBB) permeability, Reduced neuronal apoptosis, Recovery of neurological function | [112] |
rmTBI | Microglial Exosomal | Up-regulation of miR-124-3p | Inhibition of β-amyloid abnormalities, Alleviates Neurodegeneration and Improves Cognitive Outcome | [101] |
Brain damage and neurodegenerative diseases | MSC-derived secretome | NA | Inhibition of reactive astrogliosis, Reduce inflammation, Reduced microglial infiltration, Increased BBB integrity | [114] |
MDD | Microglial EVs | Up-regulation of miR-666-3p, Up-regulation of miR-7115-3p | alleviate neuroinflammation | [142] |
MDD | NK cell-derived exosomes | Up-regulation of miR-207 | Reduced release of pro-inflammatory cytokines Relief of depressive symptoms | [143] |
SCZ | MSCs-EVs | NA | Decreased glutamate levels in cerebrospinal fluid and improved core-like behaviors and biochemical markers of schizophrenia | [144] |